Multi-Criteria Decision Analysis to Prioritize the Introduction of New Vaccines in Indonesia by Using the Framework of the Strategic Multi-attribute Ranking Tool for Vaccines

LOOK AT THIS IF YOU'RE INTERESTED IN:

Examining the prioritization of the introduction of new vaccines in Indonesia based on the SMART Vaccines framework.

HOW YOU CAN USE THIS MATERIAL:

Learn how multi-criteria decision analysis (MCDA) was applied in this study then use a similar approach to assess and prioritize the introduction of new vaccines in your country.

OVERVIEW:

The Strategic Multi-Attribute Ranking Tool for Vaccines (SMART Vaccines) is a decision-support tool developed by the Institute of Medicine and the National Academy of Engineering (USA) to assist countries in prioritizing new vaccines. The primary research objective of this study was to prioritize the introduction of new vaccines in Indonesia by using the framework of SMART, focusing on Pneumococcal Conjugate Vaccine (PCV), rotavirus, Human Papilloma Virus (HPV) and Japanese Encephalitis (JE) vaccines, and exploring country-specific data related to all predefined attributes for these vaccines.

Key Points:

PCV, rotavirus and HPV vaccines should be more prioritized than JE vaccine. This ranking is in line with the WHO’s priority list, which potentially illustrates the validity and usefulness of our MCDA-approach.

You May Also Like

Linked Practitioner Perspective: Lessons from Uzbekistan on the Successful Introduction of HPV Vaccines

During our in-person learning engagement that brought together countries from the Europe-Central Asia region to discuss Immunisation Service Delivery through Primary Health Care (PHC) Platforms, Linked Network Facilitators sat down with a few immunisation experts to learn about recent successes of their national immunisation programmes. As part of this Practitioner Perspectives series, we hear from … Continued